• Poster

Cost-effectiveness and budget impact of adjunct quetiapine fumarate extended-release in patients with major depressive disorder with an inadequate response to previous therapy

Citation

Svedsäter, H., Locklear, J., Johal, S., & Özer-Stillman, I. (2011, May). Cost-effectiveness and budget impact of adjunct quetiapine fumarate extended-release in patients with major depressive disorder with an inadequate response to previous therapy. Presented at ISPOR 16th Annual International Meeting, .

Abstract